|
|
||||||||
PROTEIN AND VESICLE TRAFFICKING, CYTOSKELETON
Departments of 1Internal Medicine, 2Physiology, and 3Surgery, University of Manitoba, and 4St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada
Submitted 4 September 2006 ; accepted in final form 20 September 2006
Osteopontin (OPN) is a secreted phosphoprotein involved in cellular proliferation and associated with tumor progression. Although an intracellular form of OPN has been described, its function remains unknown. In this study, a novel nuclear location for intracellular OPN and a correlation with cell division were demonstrated. OPN distinctly localized to the nucleus in a subset of transiently transfected human embryonic kidney 293 cells. Immunoblotting confirmed the nuclear location of native OPN, and results from immunofluorescence studies suggested an association between nuclear OPN and cell cycle progression. Flow cytometry revealed that nuclear and cellular OPN content rose significantly during the S and G2/M phases, respectively. Treatment of cells with the DNA polymerase inhibitor aphidicolin prevented cell cycling and greatly reduced cellular OPN content. The intracellular location of OPN coincided with polo-like kinase-1 (Plk-1), a member of the polo-like kinase family, which, in part through their regulation of centrosome-related events, are integral to successful cellular mitosis. OPN and Plk-1 were coimmunoprecipitated from nuclear, but not cystoslic, extracts, demonstrating an interaction that is limited to the nucleus, presumably during mitosis. Deletion of the COOH terminus of OPN militated against nuclear localization and Plk-1 interaction. Elevated expression of OPN was also associated with an increase in the number of multinucleate 293 cells, whereas transfection of the COOH-terminal-deleted OPN decreased the percentage of multinucleate cells below basal levels. These findings implicate intranuclear OPN as a participant in the process of cell duplication.
cell cycle; spindle; nuclear
This article has been cited by other articles:
![]() |
H.-J. Kim, H.-J. Lee, J.-I. Jun, Y. Oh, S.-G. Choi, H. Kim, C.-W. Chung, I.-K. Kim, I.-S. Park, H.-J. Chae, et al. Intracellular cleavage of osteopontin by caspase-8 modulates hypoxia/reoxygenation cell death through p53 PNAS, September 8, 2009; 106(36): 15326 - 15331. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Tun, D. Personett, K. A. Baskerville, D. M. Menke, K. A. Jaeckle, P. Kreinest, B. Edenfield, A. C. Zubair, B. P. O'Neill, W. R. Lai, et al. Pathway analysis of primary central nervous system lymphoma Blood, March 15, 2008; 111(6): 3200 - 3210. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zahradka Novel Role for Osteopontin in Cardiac Fibrosis Circ. Res., February 15, 2008; 102(3): 270 - 272. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |